The Scleroderma Foundation announced the “Patients as Partners” program intended to help the scleroderma patient community partake with pharmaceutical and biotech companies working on clinical trial designs and other drug development initiatives for scleroderma and related conditions.
Learn more about ‘Patients as Partners’ here: http://bit.ly/24xwYvl
Learn more about scleroderma here: http://bit.ly/learnscleroderma
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?